| Section 12.1 Reserved |
|
| Section 12.2 - Precautions to be observed for the prevention of purulent conjunctivitis of the newborn |
|
| Section 12.3 - Precautions to be observed for the prevention of hemorrhagic diseases and coagulation disorders of the newborn and infants related to vitamin K deficiency |
|
| Section 98-5.1 Purpose |
|
| Section 98-5.2 Applicability |
|
| Section 98-5.3 Definitions |
|
| Section 98-5.4 Network provider type standards |
|
| Section 98-5.6 Access to providers for enrollees |
|
| Section 98-5.7 Provider directory requirements |
|
| Section 98-5.8 Additional MCO responsibilities regarding network adequacy and access |
|
| Section 98-5.9 MCO reporting on network adequacy and access |
|
| Section 98-6.0 Effective date |
|
| Section 98-5.5 Appointment wait time standards |
|